Assessment of investigational new drugs (INDs) approved in USA and Europe after early phase trials using the ESMOmagnitude of clinical benefit scale (ESMO-MCBS)-MedSci.cn

Assessment of investigational new drugs (INDs) approved in USA and Europe after early phase trials using the ESMOmagnitude of clinical benefit scale (ESMO-MCBS)

Moyers, JT; Benjamin, DJ; Brazel, D; Kumar, P; Subbiah, V

ANNALS OF ONCOLOGY, 2022; 33 (7): S1144

科室
- - 订阅+
  - 更多科室
工具
服务